{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:06:39Z","timestamp":1776920799797,"version":"3.51.2"},"reference-count":15,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,7]]},"abstract":"<jats:p>Lymphatic filariasis (LF) has been targeted for global elimination by 2020. The primary tool for the program is mass drug administration (MDA) with antifilarial medications to reduce the source of microfilariae required for mosquito transmission of the parasite. This strategy requires high MDA compliance rates. Egypt initiated a national filariasis elimination program in 2000 that targeted approximately 2.7 million persons in 181 disease-endemic localities. This study assessed factors associated with MDA compliance in year three of the Egyptian LF elimination program. 2,859 subjects were interviewed in six villages. The surveyed compliance rate for MDA in these villages was 85.3% (95% confidence interval = 83.9\u201386.5%). Compliance with MDA was positively associated with LF knowledge scores, male sex, and older age. Adverse events reported by 18.4% of participants were mild and more common in females. This study has provided new information on factors associated with MDA compliance during Egypt's successful LF elimination program.<\/jats:p>","DOI":"10.4269\/ajtmh.12-0491","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T02:46:52Z","timestamp":1370918812000},"page":"260-264","source":"Crossref","is-referenced-by-count":11,"title":["Knowledge and Practice Related to Compliance with Mass Drug Administration during the Egyptian National Filariasis Elimination Program"],"prefix":"10.4269","volume":"89","author":[{"given":"Khaled M.","family":"Abd Elaziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maged","family":"El-Setouhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reda M. R.","family":"Ramzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Progress Report 2000\u20132009 and Strategic Plan 2010\u20132020 of the Global Programme to Eliminate Lymphatic Filariasis: Halfway Towards Eliminating Lymphatic Filariasis","author":"World Health Organization","year":"2010"},{"key":"R2","series-title":"Adv Parasitol","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: treatment, control, and elimination","volume":"61","author":"Ottesen","year":"2006"},{"key":"R3","series-title":"Lancet","first-page":"992","article-title":"Effect of yearly mass drug administration with diethycarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment","volume":"367","author":"Ramzy","year":"2006"},{"key":"R4","series-title":"Global Progam to Eliminate Lymphatic Filariasis. Annual Report on Lymphatic Filariasis 2003","author":"World Health Organization","year":"2003"},{"key":"R5","series-title":"Filaria J","first-page":"7","article-title":"Defining the cost of the Egyptian lymphatic filariasis elimination programme","volume":"4","author":"Ramzy","year":"2005"},{"key":"R6","series-title":"Ann Trop Med Parasitol","first-page":"703","article-title":"Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti","volume":"98","author":"Mathieu","year":"2004"},{"key":"R7","series-title":"Public Health","first-page":"121","article-title":"Knowledge and beliefs about elephantiasis and hydrocele of lymphatic filariasis and some socio-demographic determinants in an endemic community of eastern India","volume":"118","author":"Babu","year":"2004"},{"key":"R8","series-title":"Trop Med Int Health","first-page":"862","article-title":"Participation in three consecutive mass drug administrations in Leogane, Haiti","volume":"11","author":"Mathieu","year":"2006"},{"key":"R9","series-title":"Trop Med Int Health","first-page":"1082","article-title":"The impact of six rounds of single-dose mass adminstration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes","volume":"8","author":"Ramaiah","year":"2003"},{"key":"R10","series-title":"Am J Trop Med Hyg","first-page":"753","article-title":"Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach","volume":"73","author":"Fraser","year":"2005"},{"key":"R11","series-title":"Community-Directed Treatment of Lymphatic Filariasis in Africa. Report of a Multicenter Study in Ghana and Kenya","author":"TDR","year":"2000"},{"key":"R12","series-title":"PLoS Negl Trop Dis","first-page":"e728","article-title":"2010: increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs","volume":"4","author":"Cantey","year":"2010"},{"key":"R13","series-title":"Trop Med Int Health","first-page":"701","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India","volume":"9","author":"Babu","year":"2004"},{"key":"R14","series-title":"Monitoring and Epidemiological Assessment of Mass Drug Administration in the Global Programme to Eliminate Lymphatic Filariasis: A Manual for National Elimination Programmes","author":"World Health Organization","year":"2011"},{"key":"R15","series-title":"Arab Republic of Egypt National Schistomiasis Control Project","author":"World Bank","year":"2008"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/89\/2\/article-p260.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/89\/2\/article-p260.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/89\/2\/article-p260.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T18:27:52Z","timestamp":1723055272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/89\/2\/article-p260.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,7]]},"references-count":15,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.12-0491","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,7]]}}}